Reprogrammed quiescent B cells provide an effective cellular therapy against chronic experimental autoimmune encephalomyelitis
Elisabeth Calderón‐Gómez(German Rheumatism Research Centre), Simon Fillatreau(Hôpital Necker-Enfants Malades), Anja A. Kühl(Humboldt-Universität zu Berlin), Patrícia Neves(German Rheumatism Research Centre), Toralf Roch(Charité - Universitätsmedizin Berlin), Pierre Charneau(Institut Pasteur), Sascha Rutz(Gilead Sciences (United Kingdom)), Jean Kanellopoulos(Centre National de la Recherche Scientifique), Christoph Loddenkemper(Charité - Universitätsmedizin Berlin), Ping Shen(Humboldt-Universität zu Berlin), Frank L. Heppner(Helmholtz Association of German Research Centres), Vicky Lampropoulou(National and Kapodistrian University of Athens), Stephen M. Anderton(Centre for Inflammation Research), Ulrik Stervbo(Humboldt-Universität zu Berlin)
Cited by 40
Related Papers
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
|Immunity|2017|3k
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
|Nucleic Acids Research|2017|1.7k
B cells regulate autoimmunity by provision of IL-10
|Nature Immunology|2002|1.6k
Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation
|Cell Metabolism|2016|1.5k
Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19
|Nature Neuroscience|2020|1.5k